Literature DB >> 1350678

Homozygous hereditary C3 deficiency due to a partial gene deletion.

M Botto1, K Y Fong, A K So, R Barlow, R Routier, B J Morley, M J Walport.   

Abstract

The molecular mechanism of C3 deficiency in an Afrikaans patient with recurrent pyogenic infections was studied. Restriction enzyme analysis showed a gene deletion of 800 base pairs (bp) mapping to the alpha chain of C3. Amplification of genomic DNA, using the PCR, demonstrated that the deletion included exons 22 and 23 of the C3 gene. Truncated mRNA was shown in an Epstein-Barr virus-transformed B-cell line by PCR amplification of first-strand cDNA. A consequence of this deletion was that the RNA transcribed 3' to the deletion was out of frame, resulting in formation of a stop codon 19 bp downstream from the deletion. The molecular basis of the deletion was compatible with homologous recombination between two Alu sequences located in introns 21 and 23. An unrelated nonconsanguineous relative and two of a sample of 174 Afrikaans-speaking individuals were heterozygous carriers of the same gene deletion. The wide prevalence of this null allele in this population is probably due to the effects of a small founder population. The presence of this deletion in the C3 gene is not compatible with production of any functional C3, supporting the idea that study of such patients offers a valid model for understanding physiological activities of C3 in vivo in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350678      PMCID: PMC49207          DOI: 10.1073/pnas.89.11.4957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  A family with partial and total deficiency of complement C3.

Authors:  H J Grace; G G Brereton-Stiles; G H Vos; M Schonland
Journal:  S Afr Med J       Date:  1976-01-31

2.  Homozygous C3 deficiency: detection of C3 by radioimmunoassay.

Authors:  A E Davis; J S Davis; A R Rabson; S G Osofsky; H R Colten; F S Rosen; C A Alper
Journal:  Clin Immunol Immunopathol       Date:  1977-11

3.  Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene.

Authors:  O Miura; Y Sugahara; Y Nakamura; S Hirosawa; N Aoki
Journal:  Biochemistry       Date:  1989-06-13       Impact factor: 3.162

4.  First-strand cDNA synthesis primed with oligo(dT).

Authors:  M S Krug; S L Berger
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.

Authors:  C A Alper; H R Colten; J S Gear; A R Rabson; F S Rosen
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Molecular basis of hereditary C3 deficiency.

Authors:  M Botto; K Y Fong; A K So; A Rudge; M J Walport
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination.

Authors:  L S Huang; M E Ripps; S H Korman; R J Deckelbaum; J L Breslow
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

8.  Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.

Authors:  K Neote; B McInnes; D J Mahuran; R A Gravel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family.

Authors:  J J Roord; M Daha; W Kuis; H A Verbrugh; J Verhoef; B J Zegers; J W Stoop
Journal:  Pediatrics       Date:  1983-01       Impact factor: 7.124

10.  The Alu family repeat promoter has a tRNA-like bipartite structure.

Authors:  G Paolella; M A Lucero; M H Murphy; F E Baralle
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  15 in total

1.  Homozygous hereditary C3 deficiency due to a premature stop codon.

Authors:  Edimara Da Silva Reis; Gisele Vanessa Baracho; Adriana Sousa Lima; Chuck S Farah; Lourdes Isaac
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

3.  Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Daniel Ricklin; Richard J Smith; John D Lambris
Journal:  Trends Immunol       Date:  2017-04-14       Impact factor: 16.687

Review 4.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

5.  Compound heterozygous complement C3 deficiency.

Authors:  Y Katz; R A Wetsel; M Schlesinger; Z Fishelson
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

6.  Nonsense-codon-mediated decay in human hereditary complement C3 deficiency.

Authors:  Edimara S Reis; Victor Nudelman; Lourdes Isaac
Journal:  Immunogenetics       Date:  2003-11-25       Impact factor: 2.846

7.  Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene.

Authors:  A K Ewart; W Jin; D Atkinson; C A Morris; M T Keating
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 8.  Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Qian Zhang; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

Review 9.  The cell biology of synapse formation.

Authors:  Thomas C Südhof
Journal:  J Cell Biol       Date:  2021-06-04       Impact factor: 10.539

Review 10.  Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christoph M Tang
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.